Center for Financial Planning’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
Center for Financial Planning's EW Position: Q2 2026 in Review
Center for Financial Planning increased its Edwards Lifesciences (EW) stake by 41% in Q2 2026, buying an estimated $92.1K and bringing the position to 3,816 shares worth $345K. The position accounts for 0.03% of the portfolio, ranked #135.
Center for Financial Planning first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $364K in Q1 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Center for Financial Planning held 3,816 shares of Edwards Lifesciences worth $345K as of Q2 2026.
- Center for Financial Planning bought 1,100 Edwards Lifesciences shares in Q2 2026, an estimated $92.1K.
- Edwards Lifesciences made up 0.03% of Center for Financial Planning's portfolio in Q2 2026, its #135 holding.
- Center for Financial Planning first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
- Center for Financial Planning's Edwards Lifesciences position peaked at $364K in Q1 2024.
- 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.